InvestorsHub Logo
Followers 88
Posts 1168
Boards Moderated 0
Alias Born 09/10/2017

Re: Evaluate post# 452759

Monday, 03/21/2022 2:33:38 PM

Monday, March 21, 2022 2:33:38 PM

Post# of 701436
Great news, thanks Evaluate. That’s for the BATON system which cultures both dendritic cells and T-cells. Northwest Bio’s DCVax culturing process is a little different, but there’s aspects that this patent may cover in that process as well.

It will be interesting to see what becomes of this natural approach of using dendritic cells to introduce neoantigens to T-cells for a T-cell therapy, as opposed to engineering them.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News